바이오액티브 상처 치료 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2024-2030년)

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

바이오액티브 상처 치료 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 바이오액티브 상처 치료 시장은 2030년까지 184억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 7.4%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

욕창, 당뇨병성 족부 및 기타 피부 관련 감염과 같은 만성 피부 질환의 유병률이 증가하는 추세입니다. 바이오액티브 상처 치료 제품은 앞서 언급한 상태를 치료하기 위해 효율적으로 작용하는 치료 라인을 제공합니다.

따라서, 대상 인구가 증가함에 따라 바이오액티브 상처 치료 시장은 유리한 성장을 이룰 것으로 추정됩니다. 개인 위생에 대한 환자들의 인식이 높아짐에 따라 이러한 제품에 대한 수요가 증가하고 있습니다. 인식 수준이 높아짐에 따라 환자들은 더 일찍 의사의 조언을 구하고 적시에 개입할 수 있습니다.

최근 몇 년동안 1인당 의료비 지출이 증가하고 가처분 소득이 증가함에 따라 국민들은 의료 시설에 더 많은 지출을 할 수 있게 되었고, 이는 시장 성장에 기여하고 있습니다. 환자에게 여러 가지 이점을 제공하는 여러 성분을 포함하는 복합 상처 드레싱과 같은 첨단 제품의 개발은 이러한 제품에 대한 수요를 증가시킬 것으로 예상됩니다.

바이오액티브 상처 치료 시장 보고서 하이라이트

• 습윤 상처 치료는 2023년 61.1%의 점유율을 차지하며 시장을 장악했습니다. 습윤 상처 드레싱은 적절한 수분 수준을 유지하고 탈수를 방지하며 세포 이동을 촉진하여 최적의 치유 환경을 조성하여 상처가 더 빨리 닫히도록 돕습니다.
• 일반 수술은 2023년 68.6%로 가장 큰 시장 수익 점유율을 차지했습니다. 일반 외과 부문은 성형외과, 피부과, 소아과 및 기타 용도로 세분화됩니다.
• 북미 바이오액티브 상처 치료 시장은 2023년 42.6%의 매출 점유율로 세계 바이오액티브 상처 치료 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 바이오액티브 상처 치료 시장 변수, 동향, 범위

• 시장 서론/계통 전망
• 시장 규모와 성장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 바이오액티브 상처 치료 시장 분석 툴
  • Porter의 Five Forces 분석
  • PESTEL 분석

제4장 바이오액티브 상처 치료 시장 : 제품 추정·동향 분석

• 부문 대시보드
• 바이오액티브 상처 치료 시장 : 제품 변동 분석, 백만 달러, 2023년·2030년
• 습윤 창상 치료
• 항균 창상 치료
• 액티브 드레싱

제5장 바이오액티브 상처 치료 시장 : 용도 추정·동향 분석

• 부문 대시보드
• 바이오액티브 상처 치료 시장 : 용도 변동 분석, 백만 달러, 2023년·2030년
• 일반 외과
• 저침습 수술

제6장 바이오액티브 상처 치료 시장 : 지역 추정·동향 분석

• 바이오액티브 상처 치료 시장 점유율, 지역별, 2023년·2030년, 백만 달러
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 최근 동향과 영향 분석 : 주요 시장 진출기업별
• 기업 분류
• 기업 히트맵 분석
• 기업 개요
  • B. Braun SE
  • Essity Health &Medical
  • 3M
  • Convatec Group PLC
  • Covalon Technologies Ltd
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Johnson &Johnson Services, Inc.
  • Medtronic
  • Monlnlycke Health Care AB
  • Smith+Nephew

LSH

영문 목차

영문목차

Bioactive Wound Care Market Growth & Trends:

The global bioactive wound care market is expected to reach USD 18.4 billion by 2030 and expanding at a CAGR of 7.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians' advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

Bioactive Wound Care Market Report Highlights:

• Moist wound care dominated the market and accounted for a share of 61.1% in 2023. Moist wound dressings create an optimal healing environment by maintaining the right moisture level, preventing dehydration, and promoting cell migration for faster closure.
• General surgery accounted for the largest market revenue share of 68.6% in 2023. The general surgery segment is further classified into plastic, dermatological, pediatric and others applications.
• North America bioactive wound care market dominated the global bioactive wound care market with a revenue share of 42.6% in 2023, driven by the existence of a substantial number of individuals with diabetes and the quick acceptance of modern wound treatment methods.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Bioactive Wound Care Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Bioactive Wound Care Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Bioactive Wound Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Bioactive Wound Care Market: Product Movement Analysis, USD Million, 2023 & 2030
• 4.3. Moist Wound Care
  • 4.3.1. Moist Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.1. Foam
      • 4.3.1.1.1. Foam Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.2. Alginate
      • 4.3.1.2.1. Alginate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.3. Film
      • 4.3.1.3.1. Film Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.4. Hydrocolloid
      • 4.3.1.4.1. Hydrocolloid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.5. Hydrogel
      • 4.3.1.5.1. Hydrogel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Antimicrobial Wound Care
  • 4.4.1. Antimicrobial Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.1. Silver Based
      • 4.4.1.1.1. Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.2. Non-Silver Based
      • 4.4.1.2.1. Non-Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Active Dressing
  • 4.5.1. Active Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.1. Biomaterial
      • 4.5.1.1.1. Biomaterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.1.2. Skin Substituents
      • 4.5.1.2.1. Skin Substituents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioactive Wound Care Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Bioactive Wound Care Market: Application Movement Analysis, USD Million, 2023 & 2030
• 5.3. General Surgery
  • 5.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.1.1. Plastic
      • 5.3.1.1.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.1.2. Dermatological
      • 5.3.1.2.1. Dermatological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.1.3. Pediatric
      • 5.3.1.3.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.1.4. Others
      • 5.3.1.4.1. Others General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Minimally Invasive Surgery
  • 5.4.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioactive Wound Care Market: Regional Estimates & Trend Analysis

• 6.1. Bioactive Wound Care Market Share, By Region, 2023 & 2030, USD Million
• 6.2. North America
  • 6.2.1. North America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Italy Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Spain Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Norway Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. China
    • 6.4.2.1. China Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Japan
    • 6.4.3.1. Japan Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Australia
    • 6.4.6.1. Australia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Thailand Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. UAE Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. B. Braun SE
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/Strategic Initiatives
  • 7.4.2. Essity Health & Medical
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/Strategic Initiatives
  • 7.4.3. 3M
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/Strategic Initiatives
  • 7.4.4. Convatec Group PLC
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/Strategic Initiatives
  • 7.4.5. Covalon Technologies Ltd
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/Strategic Initiatives
  • 7.4.6. DermaRite Industries LLC
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/Strategic Initiatives
  • 7.4.7. Hollister Incorporated
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/Strategic Initiatives
  • 7.4.8. Integra LifeSciences Corporation
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/Strategic Initiatives
  • 7.4.9. Johnson & Johnson Services, Inc.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/Strategic Initiatives
  • 7.4.10. Medtronic
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/Strategic Initiatives
  • 7.4.11. Monlnlycke Health Care AB
    • 7.4.11.1. Participant's Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Recent Developments/Strategic Initiatives
  • 7.4.12. Smith+Nephew
    • 7.4.12.1. Participant's Overview
    • 7.4.12.2. Financial Performance
    • 7.4.12.3. Product Benchmarking
    • 7.4.12.4. Recent Developments/Strategic Initiatives

관련자료